F98.0 N39.4
Conditions
Interventions
Group 1: Children and adolescents with nocturnal enuresis (F98.0) or daytime urinary incontinence (N39.4) and their parents are asked to participate in the following tests: General anamnesis, Child be
Sponsors
Klinik für Kinder- und Jugendpsychiatrie, Psychotherapie und Psychosomatik am Universitätsklinikum des Saarlandes
Eligibility
Sex/Gender
All
Age
5 Years to 17 Years
Inclusion criteria
Inclusion criteria: Experimental group: children and adolescents aged 5-18 years with one of the following diagnoses: F98.0 (nocturnal enuresis), N39.4 (daytime urinary incontinence). Control group: typically developed, mentally healthy children and adolescents aged 5-18 years.
Exclusion criteria
Exclusion criteria: Severe somatic diseases, diseases with severe implications on the quality of sleep (e.g. astma, Diabetes mellitus), mental retardation (IQ <70), encopresis (F98.1)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Sleep latency 2) Sleep duration 3) Sleep quality Operationalization: Actigraphy measurement over 4 days and 4 nights. Sleep data is evaluated using a specific child algorithm. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) comorbid psychiatric disorders (CBCL, Kinder-DIPS) 2) incontinence assessment (48 hour - micturation protocol, incontinence questionnaire) 3) pediatric-internistic and -neurologic status 4) intelligence test (HAWIK-IV or RIST) Data is assessed once at the beginning of the study assessment. | — |
Countries
Germany
Contacts
Public ContactAlisha Rosenthal
Klinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie am Universitätsklinikum des Saarlandes
Outcome results
None listed